June 26, 2026 12:05 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Amazon's massive India bet! Andy Jassy announces $48 billion investment after meeting PM Modi | Taratala warehouse collapse: Death toll climbs to 8, five arrested as SIT launches probe | Oil prices crash, IndiGo takes off! Aviation and fuel stocks emerge as biggest winners | Passport is a travel document, not conclusive proof of citizenship: MEA | Kolkata: Taratala warehouse roof collapses | Indian Army's Trishakti Corps restores lifeline connectivity in North Bengal between Siliguri and Mirik | 19 million barrels flow through Strait of Hormuz, Trump declares oil prices are falling | No Hindi, no NEET: Vijay reignites Tamil Nadu's biggest political flashpoints | Messi creates World Cup history with record-breaking double; Mbappe equals Klose's mark hours later | Tech giant Oracle slashes 21,000 jobs while betting big on AI
COVID19
Pixabay

US centers for disease control backs panel proposal for initial COVID-19 vaccine doses

| @indiablooms | Dec 04, 2020, at 02:59 pm

Washington/Sputnik: The US Centers for Disease Control and Prevention (CDC) adopted recommendations from an advisory panel that the first doses of a coronavirus vaccine be reserved for elderly care residents and health workers, according to a press release.

''[CDC Director Robert] Redfield supports their recommendations and has signed the memo and accepted these interim recommendations,'' the release said on Thursday.

On Tuesday, the CDC’s Advisory Committee on Immunization Practices recommended that initial vaccinations target 3 million residents in elderly care facilities and a portion of the nation’s 21 million healthcare workers.

Health workers such as nurses, whose jobs routinely place them within six feet of other people, would be first to receive the vaccine followed by workers able to follow CDC social distancing guidelines, the Advisory Committee said.

Vaccines made by Pfizer and Moderna have applied for emergency use authorization from the US Food and Drug Administration amid expectations of quick approval with first doses administered later this month. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.